These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10213974)

  • 21. Benign thyroid disease: what is the role of nuclear medicine?
    Sarkar SD
    Semin Nucl Med; 2006 Jul; 36(3):185-93. PubMed ID: 16762609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical use of nuclear medicine in the management of thyroid diseases].
    Endo K
    Nihon Rinsho; 2007 Nov; 65(11):2009-15. PubMed ID: 18018563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
    ; Sisson JC; Freitas J; McDougall IR; Dauer LT; Hurley JR; Brierley JD; Edinboro CH; Rosenthal D; Thomas MJ; Wexler JA; Asamoah E; Avram AM; Milas M; Greenlee C
    Thyroid; 2011 Apr; 21(4):335-46. PubMed ID: 21417738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
    Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
    Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case selection and restrictions recommended to patients with hyperthyroidism in South America.
    Romaldini JH
    Thyroid; 1997 Apr; 7(2):225-8. PubMed ID: 9133690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not.
    Krohn T; Hänscheid H; Müller B; Behrendt FF; Heinzel A; Mottaghy FM; Verburg FA
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4109-15. PubMed ID: 25033065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
    Al-Shakhrah IA
    Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Internal radiation therapy for malignant neoplasm].
    Yokoyama K; Kinuya S; Tonami N
    Gan To Kagaku Ryoho; 1999 May; 26(6):768-74. PubMed ID: 10410145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isotope diagnosis and isotope therapy of thyroid diseases].
    Riccabona G
    Wien Klin Wochenschr; 1968 Sep; 80(38):701-7. PubMed ID: 5703596
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment with unsealed radioisotopes.
    Greig WR; McDougall IR; Halnan KE
    Br Med Bull; 1973 Jan; 29(1):63-8. PubMed ID: 4598450
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronological change in the national health insurance reimbursement based on the DPC package payment system regarding 131I internal therapy].
    Kunishima M; Sakaguchi C; Kita T; Watanabe S; Yano F; Soga S; Shinmoto H; Kosuda S
    Kaku Igaku; 2008 May; 45(2):115-8. PubMed ID: 19591406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
    Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
    Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J; Kubinyi J; Telička Z
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage].
    Moser E
    Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.